All accepted abstracts will be available in the Journal for ImmunoTherapy of Cancer (JITC).
Onsite posters will be presented in the Poster Hall at the Walter E. Washington Convention Center in Washington, D.C. All odd numbered posters will be presented on Friday, Nov. 12, 2021. Even numbered posters will be presented Saturday, Nov. 13, 2021.
ePosters will be on display on the SITC 2021 virtual meeting platform from 7 a.m. EST on Friday, Nov. 12, 2021 until the virtual meeting platform is closed on Jan. 9, 2022.
|788||Poster Presentation||A Novel T- Lymphocyte Binding Aptamer Assembled into a Bispecifc Compound for the Treatment of Solid Tumors||Irit Carmi Levy, PhD; Erez Lavi; Neta Zilony Hanin; Zohar Pode; Karin Mizrahi; Ronit Farhi; Anastasia Paz; Neria Reiss; Chen Shimoni; Vitaliy Buravenkov; Liron Levy-Efrati; Rotem Haimovich; Ohad Glaich; Itay Liron; Hadas Aharoni Zazrin; Ido Bachelet; Raanan Berger, MD; Guy Neev||Immuno-conjugates and chimeric molecules||Antigen presenting cells;Bispecifics;Solid tumors;T cell;TLR|
|951||Oral Presentation||A Phase 1 first in human study of adenovirally transduced anti-HER2 CAR Macrophages in subjects with HER2 overexpressing solid tumors: preliminary safety, pharmacokinetics, and TME reprogramming data||Kim A. Reiss, MD; Yuan Yuan, MD, PhD; Debora Barton, MD; Amy Ronczka, BS; Daniel Cushing, PhD; Michael Klichinsky, PharmD, PhD; Sascha Abramson, PhD; Rehman Qureshi; Thomas Condamine, PhD; Elizabeth C. Dees, MD, MSC;||Clinical Trials In Progress||Adoptive immunotherapy;Antigen presenting cells;Clinical study;Clinical trial;Immune monitoring;Monocyte/Macrophage;Myeloid cells;Solid tumors;Targeted therapy;Tumor microenvironment|